International Stem Cell seeks FDA approval for Parkinson's disease cell therapy

02/18/2014 | San Diego Union-Tribune

International Stem Cell is preparing to file an FDA application to begin its stem cell therapy program for patients with Parkinson's disease. Company officials have met with the FDA to discuss preclinical testing. The treatment involves the use of progenitor cells that develop into neural cells and promote the production of dopamine.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA